Log in
Department of Medicinal Chemistry
Scientific profile
- Employees
Pracownicy zakładu
Ryszard Bugno, dr
+48 12 6623320
bugno@if-pan.krakow.pl
room 331Rafał Kurczab, dr hab.
+48 12 6623301kurczab@if-pan.krakow.plroom 326Sabina Podlewska, dr hab.
+48 12 6623301smusz@if-pan.krakow.plroom 326Grzegorz Satała, dr
+48 12 6623301satala@if-pan.krakow.plroom 326Katarzyna Szczepańska, dr
+48 12 6623301k.szczep@if-pan.krakow.plroom 326Adam Hogendorf, dr
+48 792287874ahogen@if-pan.krakow.plroom 331Katarzyna Kaczorowska, dr
+48 12 3343720k.kaczor@if-pan.krakow.plroom CEPHARES CF2.15Janusz Malarz, dr
+48 12 6623254malarzj@if-pan.krakow.plroom Radzikowskiego 176Wojciech Pietruś, dr
pietrus@if-pan.krakow.plDawid Warszycki, dr
+48 12 6623301warszyc@if-pan.krakow.plroom 326Aneta Kozioł
+48 12 6623319koziol@if-pan.krakow.plroom 330Krystyna Nędza
+48 12 6623319nedza@if-pan.krakow.plroom 330Achievements
- Publications
- Grants
Grant
Development of protocol for in silico design of compounds inhibit Ebola virus infection
Dawid Warszycki, PhD
Arylpiperazine derivatives of 3-propyl-beta-tetralonohydantoin as new 5-HT1A and 5-HT2A receptor ligands
Byrtus, H, Pawlowski, M, Duszynska, B, Wesolowska, A, Chojnacka-Wojcik, E, Bojarski, AJ
DOI:
Substituted 2-(1,2,3,4-tetrahydroisoquinoline)-butyl derivatives of azaspiro[4.5]decane-7,9-dione and phthalimide as new 5-HT<inf>1a</inf> and 5-HT<inf>2a</inf> receptor ligands
Bojarski, A.J., Misztal, S., Boksa, J., Charakchieva-Minol, S., Wesolowska, A., Tatarczyńska, E., Klodzińska, A., Chojnacka-Wójcik, E.
DOI:
Substitution mode of the amide fragment in some new N-[ω-[4-(2-methoxyphenyl)piperazin-1-yl]alkyl pyrid-2(1H)-ones and their 5-HT<inf>1A</inf>/5-HT<inf>2A</inf> activity
Paluchowska, M.H., Bugno, R., Charakchieva-Minol, S., Bojarski, A.J., Wesolowska, A.
DOI:
Arylpiperazine derivatives of 3-propyl-β-Tetralonohydantoin as new 5-HT<sup>1A</sup> and 5-HT<sup>2A</sup> receptor ligands
Byrtus, H., Pawlowski, M., Duszyńska, B., Wesolowska, A., Chojnacka-Wójcik, E., Bojarski, A.J.
DOI:
Biologically active 1-arylpiperazines. Synthesis of new N-(4-aryl-1-piperazinyl)alkyl derivatives of quinazolidin-4(3H)-one, 2,3-dihydrophthalazine-1,4-dione and 1,2-dihydropyridazine-3,6-dione as potential serotonin receptor ligands
Kowalski, P., Kowalska, T., Mokrosz, M.J., Bojarski, A.J., Charakchieva-Minol, S.
DOI: 10.3390/60900784
Substitution mode of the amide fragment in some new N-{ω-[4-(2-methoxyphenyl)piperazin-1-yl]alkyl}pyrid-2(1H)-ones and their 5-HT<sub>1A</sub>/5-HT<sub>2A</sub> activity
Paluchowska, MH, Bugno, R, Charakchieva-Minol, S, Bojarski, AJ, Wesolowska, A
DOI:
Molecules as complex adaptative systems: Constrained molecular properties and their biochemical significance
Testa, B., Bojarski, A.J.
DOI: 10.1016/S0928-0987(00)00160-3
Structure-activity relationship studies of CNS agents. Part 38 - Novel 1,4-benzoxazin-3(4H)-one, 1,2-benzoxazolin-3-one and 1,3-benzoxazolin-2,4-dione arylpiperazine derivatives with different 5-HT1A and antagonistic 5-HT2A activities
Mokrosz, MJ, Kowalski, P, Kowalska, T, Majka, Z, Duszynska, B, Bojarski, AJ, Fruzinski, A, Karolak-Wojciechowska, J, Wesolowska, A, Klodzinska, A, Tatarczynska, E, Chojnacka-Wojcik, E
DOI: 10.1002/(SICI)1521-4184(199911)332:11<373::AID-ARDP373>3.3.CO;2-C
1,2,3,4-Tetrahydroisoquinoline derivatives; lipophilicity evaluation vs. 5-HT1A receptor affinity
Bojarski, AJ, Mokrosz, MJ
DOI:
1,2,3,4-Tetrahydroisoquinoline derivatives; lipophilicity evaluation vs. 5-HT(1A) receptor affinity
Bojarski, A.J., Mokrosz, M.J.
DOI: